Hosted on MSN27d
Is Zepbound or Wegovy Better for Weight Loss? One Can Help You Shed 50 Lbs
Zepbound led to an average weight loss of 20.2 percent compared to ... while Wegovy's established cardiovascular data makes it a strong choice for heart health considerations," notes Dr. Emch.
FiercePharma4d
Lilly’s Zepbound expected to surpass Novo’s Wegovy to ‘dominate’ obesity market: GlobalData
According to the study, participants taking Zepbound lost an average of 20.2% of their starting weight after 72 weeks, ...
pharmaphorum3d
Zepbound tops Wegovy in first head-to-head weight-loss trial
31.6% of people taking tirzepatide achieved at least 25% body weight loss compared to 16.1% of those receiving semaglutide, according to Lilly, which said it plans to present the data in full at a ...
USA Today17d
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro ... "I’m just not persuaded that the data on which FDA is relying ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
gulftoday9d
The bar for successful obesity drugs is rising
In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...